Polycystic Ovary Syndrome (PCOS) - Other Places To Get Help

Organizations

InterNational Council on Infertility Information Dissemination
P.O. Box 6836
Arlington, VA 22206
Phone:	(703) 379-9178
Fax:	(703) 379-1593
E-mail:	inciidinfo@inciid.org
Web Address:	http://www.inciid.org/

The InterNational Council on Infertility Information Dissemination (INCIID-pronounced "inside") is a nonprofit organization that helps individuals and couples explore their family-building options. INCIID provides current information and immediate support regarding the diagnosis, treatment, and prevention of infertility and pregnancy loss and offers guidance to those considering adoption or child-free lifestyles.

American College of Obstetricians and Gynecologists (ACOG)
409 12th Street SW
P.O. Box 96920
Washington, DC 20090-6920
Phone:	(202) 638-5577
E-mail:	resources@acog.org
Web Address:	www.acog.org

American College of Obstetricians and Gynecologists (ACOG) is a nonprofit organization of professionals who provide health care for women, including teens. The ACOG Resource Center publishes manuals and patient education materials. The Web publications section of the site has patient education pamphlets on many women's health topics, including reproductive health, breast-feeding, violence, and quitting smoking.

American Fertility Association
305 Madison Avenue
Suite 449
New York, NY 10165
Phone:	1-888-917-3777
E-mail:	info@theafa.org
Web Address:	www.theafa.org

The American Fertility Association is a national nonprofit organization that helps women and men facing decisions related to family building and reproductive health-from prevention and treatment of infertility to social and psychological concerns. The mission of AFA is to serve as a lifetime resource for men and women who need reproductive information and support and to forward the causes of adoption and reproductive health through advocacy, education, awareness building, and research funding.

National Women's Health Information Center
8270 Willow Oaks Corporate Drive
Fairfax, VA 22031
Phone:	1-800-994-9662 (202) 690-7650
Fax:	(202) 205-2631
TDD:	1-888-220-5446
Web Address:	www.womenshealth.gov

The National Women's Health Information Center (NWHIC) is a service of the U.S. Department of Health and Human Services Office on Women's Health. NWHIC provides women's health information to a variety of audiences, including consumers, health professionals, and researchers.

Polycystic Ovarian Syndrome Association (PCOSA)
P.O. Box 3403
Englewood, CO 80111
E-mail:	info@pcosupport.org
Web Address:	www.PCOSupport.org

The Polycystic Ovarian Syndrome Association (PCOSA) provides a central and comprehensive set of resources for information on polycystic ovary syndrome (PCOS). PCOSA also provides an advocacy network, including social support, for women with PCOS and for their families.

WebMD Medical Reference from Healthwise

Last Updated: January 23, 2008

This information is not intended to replace the advice of a doctor. Healthwise disclaims any liability for the decisions you make based on this information.

Polycystic Ovary Syndrome (PCOS) Topics

Bladder Control Problems?
Have a Life Less Interrupted

Important Safety Information | Prescribing Information

ENABLEX is a prescription medicine used in adults to treat the following symptoms due to a condition called overactive bladder:

· having a strong need to go to the bathroom right away (also called "urgency")
· leaks or wetting accidents (also called "urinary incontinence")
· having to go to the bathroom too often (also called "urinary frequency")

IMPORTANT SAFETY INFORMATION

You should not take once-daily ENABLEX if you have certain types of stomach problems, glaucoma, or have trouble emptying your bladder. Side effects of ENBLEX include blurred vision, and more commonly dry mouth, constipation, indigestion, and abdominal pain. Use caution when doing certain activities until you know how ENBALEX affects you.

As You Journey through Menopause, Vivelle-Dot Is By Your Side

VIVELLE-DOT (estradiol transdermal system) IS AVAILABLE BY PRESCRPTION ONLY.

INDICATION

Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.

IMPORTANT SAFETY INFORMATION

Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).

Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).

Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.

The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.

You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Full Prescribing Information for Vivelle-Dot.

Prescribing Information